U.S. markets open in 3 hours 42 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
8.23-0.18 (-2.14%)
At close: 04:00PM EST
8.25 +0.02 (+0.24%)
Pre-Market: 04:05AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close8.41
Bid0.00 x 2200
Ask0.00 x 1800
Day's Range8.22 - 8.51
52 Week Range7.73 - 13.30
Avg. Volume10,059,077
Market Cap9.437B
Beta (5Y Monthly)1.30
PE Ratio (TTM)12.47
EPS (TTM)0.66
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 27, 2017
1y Target Est11.36
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
11% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for TEVA

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Teva Pharmaceutical Industries
    Analyst Report: Teva Phar Inds LtTeva Pharmaceutical Industries Ltd. is the world's largest generic pharmaceutical manufacturer, with roughly 120 billion tablets and capsules produced annually. The company has over 37,000 employees and a presence in 60 countries. One of every 12 generic prescriptions in the U.S. is filled with Teva products.
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • Motley Fool

    2 Best Warren Buffett Value Stocks to Buy Right Now

    Berkshire Hathaway CEO Warren Buffett is one of the most successful value investors of all time. Although classic value stocks fell out of favor during the nearly decade-long bull market over the course of 2010 to 2020, and Berkshire's stock underperformed some major U.S. stock indexes as a result, these tried and true investing vehicles are making a furious comeback during this current bear market. The long and short of it is that the increasing likelihood of rising interest rates and stubbornly high levels of inflation ought to favor Buffett's value-oriented approach to investing over narrative-driven growth stocks in 2022.

  • Insider Monkey

    10 Best Stocks to Buy Today According to Value Investor David Abrams

    In this piece, we will take a look at the 10 best stocks to buy today according to value investor David Abrams. If you want to take a look only at the top five stocks in this list then head on over to 5 Best Stocks to Buy Today According to Value Investor David Abrams. […]

  • Motley Fool

    3 Turnaround Stocks That Can Bounce Back Big Time in 2022

    If we strictly looked at the performance of the major U.S. stock indexes, 2021 was a great year. While no investor enjoys seeing their stocks go in reverse, patience has a way of paying off handsomely in the stock market. In 2022, the following trio of turnaround stocks have the catalysts needed to bounce back in a big way.